November 22nd 2024
At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.
November 20th 2024
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.
November 13th 2024
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
ACIP Revises Adult Pneumococcal Vaccination Recommendations: Good, Bad, and Ugly
The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?
Beyond Boomers: CDC Urges HCV Screening for All US Adults
HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.
COVID-19 and Influenza: How Can We Mitigate Certain Calamity?
A pulmonary and critical care specialist identifies 4 factors that will, in part, determine the severity of the 2020-2021 flu season and that can inform preparation.
Remdesivir New Drug Application Submitted to FDA
The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.
COVID-19 Vaccines: Will Next-gen Platforms Be First?
There are nearly 30 COVID-19 vaccine candidates in human trials. Confused? Here's a short primer on the old and new development platforms and the pros and cons.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 10, 2020
US confirmed cases of COVID-19 surpassed 5 million; global recoveries have exceeded 12 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 5, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 4, 2020
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 3, 2020
US confirmed cases of COVID-19 number nearly 4.6 million; global cases have surpassed 18 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning
The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 31, 2020
US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 30, 2020
COVID-19 Update: US and Global Cases and Recoveries as of July 28, 2020
Global confirmed cases of COVID-19 are approaching 16.5 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Phase 3 Trial of Moderna/NIH COVID-19 Vaccine Candidate is Launched
COVID-19 vaccine hopeful mRNA-1273 will be administered to 30,000 trial volunteers at 89 US research sites.
COVID-19 Update: US and Global Cases and Recoveries as of July 27, 2020
Global confirmed cases of COVID-19 have surpassed 16 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Study: After COVID-19, Symptoms Persist for Majority of Patients
JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.
Survey: More than One-quarter of Parents Hesitant to Vaccinate Children Against Flu
Parental doubts about efficacy drive flu-shot hesitancy, according to a new survey, and impact routine vaccination rates, as well.
FDA Issues EUA for Combined Influenza-COVID-19 Diagnostic
The EUA is the third for diagnostics designed for detection and differentiation of the viruses that cause COVID-19 and the flu.
Scientists Appeal to WHO to Recognize COVID-19 Airborne Transmission Threat
A letter to the World Health Organization signed by more than 200 scientists from around the world strongly urges the agency to acknowledge airborne transmission of the SARS-Cov2 virus.
NIH: Dexamethasone Recommendations for Patients with COVID-19
The NIH COVID-19 Treatment Guidelines Panel published guidelines on use of the corticosteroid dexamethasone in patients severely ill with COVID-19.
511 Epidemiologists Weigh In on Resuming 20 Everyday Activities
The New York Times asked 511 epidemiologists when they might resume hair cuts, shaking hands, air travel, bus rides, and 15 other "normal" activities suspended during COVID-19 social distancing.
Asymptomatic Cornovavirus Spread: What the WHO Meant
"Asymptomatic coronavirus spread is rare." World Health Organization explains the miscommunication.
Remdesivir Bests Placebo in Time to Recovery from COVID-19
The recovery rate of patients with severe COVID-19 infection who received remdesivir was 31% faster than those in a placebo group, according to the NIH.
COVID-19 Impressions & Misconceptions in the US and UK
One-quarter of US and UK adults indicated a package from China may transmit the SARS-CoV-2 virus. Click through more perceptions, true and false, from a recent survey.
Return to Work Criteria for HCP After COVID-19
CDC return-to-work criteria for healthcare workers with confirmed or suspected COVID-19 are publisehd to guide administrative decision making.
Study: Remdesivir Resulted in Clinical Improvement in 68% of COVID-19 Patients
A new study found patients hospitalized with severe complications of COVID-19 demonstrated significant clinical improvement with remdesivir treatment.
Experimental COVID-19 Treatments May Put CVD Patients at Risk
Hydroxychloroquine and azithromycin are proposed as treatments for COVID-19 but in patients with existing CV disease could be deadly.
Exposed but Asymptomatic: CDC Guidance on Work Safety
New CDC interim guidance for essential workers exposed to COVID-19 outlines precautions for employee and employer.
Hydroxychloroquine to be Tested as COVID-19 Prophylaxis
Health care workers and first responders will be volunteer participants in the Henry Ford Health System trial of the drug as preventive therapy against COVID-19.
COVID-19 Update: Global Confirmed Cases as of April 8, 2020
The latest COVID-19 data on confirmed cases, fatalities, and more from the Johns Hopkins COVID-19 interactive map.